Endovascular aortic aneurysm repair with iliac branched device for treatment of aortoiliac aneurysms: short-term results

IF 0.2 Q4 SURGERY
Hisham Desoky, Samir A. Zied, Mahmoud Nasser
{"title":"Endovascular aortic aneurysm repair with iliac branched device for treatment of aortoiliac aneurysms: short-term results","authors":"Hisham Desoky, Samir A. Zied, Mahmoud Nasser","doi":"10.4103/ejs.ejs_278_22","DOIUrl":null,"url":null,"abstract":"Background Abdominal aortic aneurysm (AAA) is a life-threatening disease, which may be discovered incidentally or upon its rupture. The endovascular AAA repair ‎(EVAR) has become the treatment of choice owing ‎to its minimal invasiveness. It is challenged by the presence of concomitant common iliac artery aneurysms as there is no proper sealing zone distal to the aneurysm. ‎Currently, advances in ‎graft technology yielded the iliac branch devices (IBDs) to be the solution to keep the internal iliac artery blood flow and preclude pelvic ischemic complications.‎ Aim This study aimed to present our experience and the short-term outcome of using IBD during AAA repair. Patients and methods This is a retrospective study that included 20 patients with aortoiliac aneurysms indicating interventions. After proper selection, patients were treated with EVAR with Cook Zenith IBD implantation. Results Technical and clinical success was achieved in all ‎cases. Primary patency was 100% at 1 year. No IBD-related complications were encountered. Type II endoleak ‎was present in two cases with stable course and stationary sac size ‎not requiring intervention. Conclusion The short-term patient follow-up in this study highlighted that when patients are ‎properly selected and precise technical manipulation is secured, EVAR-IBD is a ‎feasible, effective, and safe treatment ‎of choice for patients with AAA and common iliac artery ‎aneurysms. It offered substantial clinical and ‎technical success, and iliac patency, with ‎no procedure-related significant morbidity or ‎mortality.","PeriodicalId":43393,"journal":{"name":"Egyptian Journal of Surgery","volume":"41 1","pages":"1605 - 1610"},"PeriodicalIF":0.2000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ejs.ejs_278_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0

Abstract

Background Abdominal aortic aneurysm (AAA) is a life-threatening disease, which may be discovered incidentally or upon its rupture. The endovascular AAA repair ‎(EVAR) has become the treatment of choice owing ‎to its minimal invasiveness. It is challenged by the presence of concomitant common iliac artery aneurysms as there is no proper sealing zone distal to the aneurysm. ‎Currently, advances in ‎graft technology yielded the iliac branch devices (IBDs) to be the solution to keep the internal iliac artery blood flow and preclude pelvic ischemic complications.‎ Aim This study aimed to present our experience and the short-term outcome of using IBD during AAA repair. Patients and methods This is a retrospective study that included 20 patients with aortoiliac aneurysms indicating interventions. After proper selection, patients were treated with EVAR with Cook Zenith IBD implantation. Results Technical and clinical success was achieved in all ‎cases. Primary patency was 100% at 1 year. No IBD-related complications were encountered. Type II endoleak ‎was present in two cases with stable course and stationary sac size ‎not requiring intervention. Conclusion The short-term patient follow-up in this study highlighted that when patients are ‎properly selected and precise technical manipulation is secured, EVAR-IBD is a ‎feasible, effective, and safe treatment ‎of choice for patients with AAA and common iliac artery ‎aneurysms. It offered substantial clinical and ‎technical success, and iliac patency, with ‎no procedure-related significant morbidity or ‎mortality.
髂支化装置修复血管内主动脉瘤治疗主髂动脉瘤的近期疗效
背景腹主动脉瘤(AAA)是一种危及生命的疾病,可偶然发现或破裂。血管内AAA修复‎(EVAR)由于‎至其最小的侵入性。同时存在髂总动脉瘤是一个挑战,因为动脉瘤远端没有合适的密封区。‎目前‎移植技术使髂支装置(IBD)成为保持髂内动脉血流和预防骨盆缺血性并发症的解决方案。‎ 目的本研究旨在介绍我们在AAA修复过程中使用IBD的经验和短期结果。患者和方法这是一项回顾性研究,包括20例指示干预措施的主动脉髂动脉瘤患者。经过适当的选择,患者接受EVAR治疗,植入Cook-Zenith IBD。结果所有患者均取得了技术和临床上的成功‎案例。1年时原发性通畅率为100%。未发现IBD相关并发症。II型内漏‎出现在两个病程稳定且囊大小固定的病例中‎不需要干预。结论本研究中的短期患者随访强调,当患者‎正确选择并确保精确的技术操作,EVAR-IBD是‎可行、有效、安全的治疗‎AAA和髂总动脉患者的首选‎动脉瘤。它提供了大量的临床和‎技术成功,髂关节通畅‎无与手术相关的重大发病率或‎死亡率
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书